Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.

Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA.

Cell. 2003 Apr 18;113(2):207-19.

2.

Another tie that binds the MTA family to breast cancer.

Kumar R.

Cell. 2003 Apr 18;113(2):142-3. Review.

3.

Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells.

Fujita N, Kajita M, Taysavang P, Wade PA.

Mol Endocrinol. 2004 Dec;18(12):2937-49. Epub 2004 Sep 9.

PMID:
15358836
4.

MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.

Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, Wade PA.

Cell. 2004 Oct 1;119(1):75-86.

5.

The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.

Toh Y, Nicolson GL.

Clin Exp Metastasis. 2009;26(3):215-27. doi: 10.1007/s10585-008-9233-8. Epub 2008 Dec 31. Review.

PMID:
19116762
6.

Emerging roles of MTA family members in human cancers.

Kumar R, Wang RA, Bagheri-Yarmand R.

Semin Oncol. 2003 Oct;30(5 Suppl 16):30-7. Review.

PMID:
14613024
9.

Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.

Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF, Fu YP, Cheng TC, Wu PE, Shen CY.

J Biomed Sci. 2006 May;13(3):419-32. Epub 2006 Feb 25.

PMID:
16502042
10.

The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma.

Dong H, Guo H, Xie L, Wang G, Zhong X, Khoury T, Tan D, Zhang H.

PLoS One. 2013 May 3;8(5):e62986. doi: 10.1371/journal.pone.0062986. Print 2013.

11.

The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.

Dhasarathy A, Kajita M, Wade PA.

Mol Endocrinol. 2007 Dec;21(12):2907-18. Epub 2007 Aug 30.

13.

The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.

Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, Cano A.

J Cell Sci. 2003 Feb 1;116(Pt 3):499-511. Erratum in: J Cell Sci. 2016 Mar 15;129(6):1283.

14.

Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway.

Zhang H, Singh RR, Talukder AH, Kumar R.

Genes Dev. 2006 Nov 1;20(21):2943-8. Epub 2006 Oct 18.

16.

Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.

Brüning A, Blankenstein T, Jückstock J, Mylonas I.

Cancer Metastasis Rev. 2014 Dec;33(4):943-51. doi: 10.1007/s10555-014-9520-6. Review.

PMID:
25319202
17.

Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.

Mazumdar A, Wang RA, Mishra SK, Adam L, Bagheri-Yarmand R, Mandal M, Vadlamudi RK, Kumar R.

Nat Cell Biol. 2001 Jan;3(1):30-7.

PMID:
11146623
18.

Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.

Mishra SK, Talukder AH, Gururaj AE, Yang Z, Singh RR, Mahoney MG, Francí C, Vadlamudi RK, Kumar R.

J Biol Chem. 2004 Jul 30;279(31):32709-15. Epub 2004 May 28.

19.

RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.

van Bragt MP, Hu X, Xie Y, Li Z.

Elife. 2014 Nov 21;3:e03881. doi: 10.7554/eLife.03881.

20.

Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1.

Khaleque MA, Bharti A, Gong J, Gray PJ, Sachdev V, Ciocca DR, Stati A, Fanelli M, Calderwood SK.

Oncogene. 2008 Mar 20;27(13):1886-93. Epub 2007 Oct 8.

PMID:
17922035

Supplemental Content

Support Center